Inhibition of SIRT7 overcomes sorafenib acquired resistance by suppressing ERK1/2 phosphorylation via the DDX3X-mediated NLRP3 inflammasome in hepatocellular carcinoma
Yuna Kim, Yuna Kim, Kwan‐Young Jung, Yun Hak Kim, Yun Hak Kim, Pan Xu, Baeki E. Kang, Yunju Jo, Navin Pandit, Jeongho Kwon, Karim Gariani, Joanna Gariani, Junguee Lee, Jef Verbeek, Seungyoon Nam, Sung‐Jin Bae, Ki‐Tae Ha, Hyon‐Seung Yi, Minho Shong, Kyun‐Hwan Kim, Doyoun Kim, Hee Jung Jung, Chang-Woo Lee, Kwang Rok Kim, Kristina Schoonjans, Johan Auwerx, Dongryeol Ryu
Topics & Concepts
SorafenibSirtuinInflammasomeCancer researchHepatocellular carcinomaPharmacologyMedicineChemistryAcetylationInternal medicineReceptorGeneBiochemistrySirtuins and Resveratrol in MedicineInflammasome and immune disordersEndoplasmic Reticulum Stress and Disease